Supplying the World
Our facility has been exporting its products across the globe since commencing operation. Shipping to over 50 countries, we confidently service East & South Eastern Asia, Europe, Central & South America, the Indian Subcontinent, the Middle East & Africa.
By adhering to stringent standards and implementing robust quality control measures, we guarantee the consistent and expedited delivery of world-class Hyoscine products that meet the needs of our customers around the globe.
Our Competitive Advantage
Australian Alkaloids is an Active Pharmaceutical Ingredient manufacturer, with a clear focus on Hyoscine (Scopolamine) derivatives.
Our facility is located in the heart of the natural source of Hyoscine, with our operation stretching from the Duboisia plantations through to the packaging of final product.
This vertical integration ensures a consistent supply of high-quality raw materials, allowing us to maintain a competitive edge and deliver reliable, cost-effective solutions to our customers.
Supplying the World
Our facility has been exporting its products across the globe since commencing operation. Shipping to over 50 countries, we confidently service East & South Eastern Asia, Europe, Central & South America, the Indian Subcontinent, the Middle East & Africa.
By adhering to stringent standards and implementing robust quality control measures, we guarantee the consistent and expedited delivery of world-class Hyoscine products that meet the needs of our customers around the globe.
Our Competitive Advantage
Australian Alkaloids is an Active Pharmaceutical Ingredient manufacturer, with a clear focus on Hyoscine (Scopolamine) derivatives.
Our facility is located in the heart of the natural source of Hyoscine, with our operation stretching from the Duboisia plantations through to the packaging of final product.
This vertical integration ensures a consistent supply of high-quality raw materials, allowing us to maintain a competitive edge and deliver reliable, cost-effective solutions to our customers.
Supplying the World
Our facility has been exporting its products across the globe since commencing operation. Shipping to over 50 countries, we confidently service East & South Eastern Asia, Europe, Central & South America, the Indian Subcontinent, the Middle East & Africa.
By adhering to stringent standards and implementing robust quality control measures, we guarantee the consistent and expedited delivery of world-class Hyoscine products that meet the needs of our customers around the globe.
Our Competitive Advantage
Australian Alkaloids is an Active Pharmaceutical Ingredient manufacturer, with a clear focus on Hyoscine (Scopolamine) derivatives.
Our facility is located in the heart of the natural source of Hyoscine, with our operation stretching from the Duboisia plantations through to the packaging of final product.
This vertical integration ensures a consistent supply of high-quality raw materials, allowing us to maintain a competitive edge and deliver reliable, cost-effective solutions to our customers.
Our History
Having commenced production in 1987, our facility is the only dedicated producer of Hyoscine derivatives in the world. Our company remains privately owned with the manufacturing operations located in close proximity to the nearby plantations of starting material.
Our operation was first licensed by the Australian Therapeutic Goods Administration (TGA) in 1991 and has been continuously licensed from that time. Our facility maintains compliance to the relevant PIC/S Guide to Good Manufacturing Practice for Medicinal Products – Part II and holds current certificates of Good Manufacturing Practice (GMP) issued by the TGA and the Brazilian Health Regulatory Agency(ANVISA).
A Certificate of Suitability (CEP) for Hyoscine Butylbromide, is held with the European Directorate of Quality Medicines (EDQM) since 2016.
An Active Substance Master File (ASMF) for Hyoscine Butylbromide is available, with filings already held by multiple regulatory authorities worldwide.
Our Products
Australian Alkaloids produces a Hyoscine Butylbromide API and Hyoscine Hydrobromide Intermediate. Both products are certified to the latest European Pharmacopoeia.
Our History
Having commenced production in 1987, our facility is the only dedicated producer of Hyoscine derivatives in the world. Our company remains privately owned with the manufacturing operations located in close proximity to the nearby plantations of starting material.
Our operation was first licensed by the Australian Therapeutic Goods Administration (TGA) in 1991 and has been continuously licensed from that time. Our facility maintains compliance to the relevant PIC/S Guide to Good Manufacturing Practice for Medicinal Products – Part II and holds current certificates of Good Manufacturing Practice (GMP) issued by the TGA and the Brazilian Health Regulatory Agency(ANVISA).
A Certificate of Suitability (CEP) for Hyoscine Butylbromide, is held with the European Directorate of Quality Medicines (EDQM) since 2016.
An Active Substance Master File (ASMF) for Hyoscine Butylbromide is available, with filings already held by multiple regulatory authorities worldwide.
Our Products
Australian Alkaloids produces a Hyoscine Butylbromide API and Hyoscine Hydrobromide Intermediate. Both products are certified to the latest European Pharmacopoeia.